Michael Krainer
Impact in
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 55
- Cancer Treatment and Pharmacology 11
- HER2/EGFR in Cancer Research 9
- Cancer Cells and Metastasis 8
-
- Cell death mechanisms and regulation 10
- Co-authors
- Dietmar Pils (20 shared papers)Robert Zeillinger (22 shared papers)Peter Horak (25 shared papers)Christoph Zielinski (23 shared papers)Daniel A. Haber (6 shared papers)Reinhard Horvat (12 shared papers)E. Fritz (4 shared papers)Michael G. FitzGerald (4 shared papers)
- Journals
- European Journal of Cancer (7 papers)Journal of Clinical Oncology (6 papers)Cancer (5 papers)Cancers (4 papers)Cancer Research (4 papers)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Michael Krainer
105 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 110
- Oncology 1.5k
- Cancer Research 692
- Hematology 428
- Immunology 767
- Reproductive Medicine 189
Countries citing papers authored by Michael Krainer
This map shows the geographic impact of Michael Krainer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Krainer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Krainer more than expected).
Fields of papers citing papers by Michael Krainer
This network shows the impact of papers produced by Michael Krainer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Krainer. The network helps show where Michael Krainer may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Krainer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 409 | |
| 2 | 1996 | 289 | |
| 3 | 1997 | 159 | |
| 4 | 1991 | 128 | |
| 5 | 2005 | 122 | |
| 6 | 2004 | 118 | |
| 7 | 1991 | 110 | |
| 8 | 2010 | 90 | |
| 9 | 2005 | 77 | |
| 10 | 1993 | 74 | |
| 11 | 2014 | 72 | |
| 12 | 1997 | 72 | |
| 13 | 2007 | 71 | |
| 14 | Predictive value of interleukin-6 and neopterin in patients with multiple myeloma. | 1991 | 69 |
| 15 | 1997 | 66 | |
| 16 | 2006 | 62 | |
| 17 | 2007 | 51 | |
| 18 | 2004 | 50 | |
| 19 | 2012 | 49 | |
| 20 | 2014 | 47 |
About Michael Krainer
Michael Krainer is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Immunology and Cancer Research, having authored 106 papers that have together received 3.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (22 papers), Cancer Treatment and Pharmacology (11 papers), Cell death mechanisms and regulation (10 papers), HER2/EGFR in Cancer Research (9 papers), Cancer Cells and Metastasis (8 papers), Multiple Myeloma Research and Treatments (7 papers), Radiopharmaceutical Chemistry and Applications (7 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (692 citations), Hematology (428 citations), Immunology (767 citations) and Reproductive Medicine (189 citations). Michael Krainer has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Dietmar Pils, Robert Zeillinger, Peter Horak, Christoph Zielinski, Daniel A. Haber, Reinhard Horvat, E. Fritz, Michael G. FitzGerald, Kurt J. Isselbacher and Sandra Tomek. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, Cancer, Cancers and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.